Table 1.
Integration of a secondary Mos1 plasmid in primary nos-Mos1 strains
| nos-Mos line | No. injected | No. of G0 survivors (%) | TL* | TF,† % |
|---|---|---|---|---|
| AenMn no. 2 | 354 | 100: 61♂, 39♀ (28) | 1 | 2 |
| AenMn no. 3 | 292 | 104: 63♂, 41♀ (35) | 4 | 8 |
| AenMn no. 4 | 288 | 83: 28♂, 55♀ (29) | 0 | <2.4 |
| AenMn no. 5 | 415 | 28: 14♂, 14♀ (6.7) | 2 | 14 |
| AenMn2 no. 18 | 327 | 125: 65♂, 60♀ (38) | 1 | 1.6 |
| Total | 1,676 | 440: 231♂, 209♀ (26) | 8 | 3.6 |
| Higgs white-eye (control) | 992 | 361: 205♂, 156♀ (36) | 0‡ | 0.0 |
*TL, number of independent GFP-marked transformed lines obtained.
†TF, transformation frequency represents the number of independent transformed lines generated per fertile G0 survivor.
‡48,483 G1 progeny screened from 43 male and 20 female pools.